English
Transcription
English
The Israel-Europe R&D Directorate Bar Mitzvah - 13 years of success Years of Israeli Association in the European Framework Programme for Research and Technological Development A Salute to the Framework Programme The Unique Contribution to Israeli R&D A Bouquet of Israeli Success in the Seventh Framework Programme How to Participate in European Research Projects Ministry of Industry, Trade and Labor Ministry of Science and Technology H A A R E T Z Special Supplement 2 13 The Israel-Europe R&D Directorate 2 Contents 3 FP7 Structure and Budget Overview Bar Mitzvah - 13 years of success Years of Israeli Association in the European Framework Programme for Research and Technological Development A Salute to the Framework Programme 4 Greetings 6 Israeli Results in FP7 The Unique Contribution to Israeli R&D A Bouquet of Israeli Success in the Seventh Framework Programme 7 The Gateway to Europe How to Participate in European Research Projects Ministry of Industry, Trade and Labor Ministry of Science and Technology An Interview with Marcel Shaton, ISERD's General Manager H A A R E T Z Special Supplement 12 A Bouquet of Israeli Success Stories of Israeli Success in the European Framework Programme 16 Winners Panel: When Israeli Capabilities meet European Capabilities 19 How to Participate in European R&D Projects? Ten recommendations 20 ISERD's Team H A A R E T Z Special Supplement Editor: Joel Tsafrir | Production Manager: Smadar Averbuch | Graphic Design: Climax Studio www.climax-design.co.il Advertising Manager: Haim Vienta Tel. 03-5121742 | Translation: Leehee Goldenberg Commercial Manager: Hagit Levi | Print: Graphoprint Haaretz Haaretz, Commercial Department, 21 Shoken St., Tel Aviv, Israel Tel:+972 3 5131311, Fax: +972 3 5121170 The publisher is not responsible to the content of the ads. The publisher wishes to clarify that the articles and/or the ads aren't any recomandation of any sort. 3 13 Bar Mitzvah 3 Bar Mitzvah Bar Mitzvah Bar Mitzvah The Seventh Framework Programme (FP7) Structure & Budget Overview (in millions of euros) Cooperation 32,463 Health 6,150 Food, Agriculture, Fisheries and Biotechnology 1,935 Information and 9,050 Communication Technologies Nanotechnologies, Materials, Production 3,475 Energy 2,350 Environment 1,890 Initial Training Networks People (Marie Curie Actions) Life Long Training and Career Development 4,750 Industry-Academia Path Ways & partnerships International Dimension Specific Actions Capacities 4,097 Research infrastructures 1,715 Research for the benefit of small and medium sized enterprises (SME's) 1,336 Regions of knowledge 126 Research potential 340 Transport & Aeronautics 4,160 Socio-Economic Sciences & Humanities 623 Space 1,430 Science in society 330 Security 1,400 Activities of international co-operation (INCO) 180 Starting Independent Research Grants IDEAS (European Research Council-ERC) Advanced Investigator Grant 7,510 Total FP7 Budget Support for the coherent 70 development of research policies 48,820 Source: ISERD Database From the award ceremonies honoring the winners in EU FP7 2007, 2008 4 13 4 Dear Readers, Congratulations! Israel is marking its 13th year, its "Bar Mitzvah" since having joined the European Framework Programme. Throughout these years, Israel has proved that its membership in the Programme was not simply a political gesture, rather a strategic long-term development, which has to date significantly helped reinforce the research and development ties between Israel and the European community. In addition, it has fulfilled Photo: Ofer Vaaknin the expectations and interests of both sides, who maintain a wide array of long-term close ties. We are currently demarcating the halfway point of the Seventh Framework Programme, which articulates a significant step-up in advancing R&D in Europe. The sum allocated to support R&D in the current programme is 50 billion Euros spread across 7 years, of these, more that 32 billion Euros have been allocated to support international cooperation in R&D. Like its predecessors, the Seventh Programme grants a unique opportunity to organizations and companies in Israel to form business and research collaborations with leading organizations in Europe as well as provides access for strategic integration in the research, development and marketing frameworks of the continent. Israel's full partnership in the Programme testifies to its leading role as a scientific-technological player in the European forum as well as to the achievements stemming from its participation in the previous Framework Programmes. For example, in the Sixth Framework Programme, organizations from Israel received research grants totaling 203 million Euros, making the Programme a major source for R&D grants for Israeli companies, alongside the grants from Israel's Chief Scientist. It is important to remember that the financing options here are particularly attractive and the research's results remain the company's property. The European Framework Programme is currently marking 25 years since its inception. Within this historical perspective one can say that it has filled a unique and important position in Europe's integration and the increased competitive capabilities of the European economy, all the while strengthening the scientific-technological cooperation between the continent's countries. Regarding Israel, there is no doubt that the Programme, beyond representing the faith given to Israeli industry and technology, has helped strengthen Israel's integration into the European Research Area and has created the support infrastructure and framework of activities which allowed it to find the tremendous potential within the Framework regarding manpower, corporate and business ties and commercial-industrial leveraging. Israeli participation in the European R&D Programme has significant influence on Israel's development and its status in the fields of science and technology. Israel arrived at the Seventh Programme with significant experience from the three previous Programmes. It is important to remember that Israel is the only country outside of Europe that is an associated of the European R&D programme. This on its own presents an ongoing challenge of making itself as a significant player in the European scientific-technological arena. The impressive achievements so far, stemming from the Israeli industry and academia, testify to the manner in which the vision of participating in the European Framework Programme has been visionary and has proved itself. I truly believe that the European Framework Programme will continue to represent an incentive to the realization of large projects, rich in vision and financing, through exposure to new technologies and partnerships, developing business relationships and penetrating into new markets. All these elements are of significant importance to Israel and we must act to preserve and strengthen them. Sincerely yours, Binyamin (Fuad) Ben-Eliezer Minister of Industry, Trade and Labor Focusing on leading infrastructure-strategic research, bridging between basic research and applied research, the Ministry of Science and Technology sees the European Framework programme as a very important leverage and as an outstanding infrastructure for realizing this vision. Israel is currently marking 13 years since joining the European Program, an additional testimony to the Photo: Avi Ohayun, La"m success of the scientific-technological partnership between Israel and Europe. The European Framework Program is an additional important stage in the national effort to advance and foster Israeli science. Regarding the market’s globalization process, the development of science and technology must be done in close cross-border cooperation with other scientific, industrial and academic factors world wide, following a multi-disciplinary approach and in the spirit of cooperation, with mutual flows of information and feedback. All of these are expressed in the European Framework Program and provide a small country like Israel with the ability to keep a high level of scientific research, while expressly fostering a strong amount of scientific foreign ties. The verity of this statement is strengthened and continues yearly, so long as the trend of globalization of sciences continues to deepen. In addition to the significant benefits Israel receives through its participation in the Program, it is important to discuss a subject with significant national importance, one that the Ministry of Science allocates significant research to: the return of Israeli scientists. In this respect it should be noted, that the European Framework Program granted dozens of scholarships to Israeli researchers and scientists from industry and academia to fund their return from the United States. In fact, Israel is in the top spot regarding scholarship winner for the last call for proposals intended to return researchers to Europe, and for this matter Israel is considered part of Europe. During the internal discussion in Israel regarding Israel’s participation in the Framework Programme, there were concerns that Israeli scientists would not be able to enjoy these scholarships as they don’t actually express Israeli-European collaboration per se. However, thanks to Israel’s actions it was decided that these scholarships would also be available for Israeli researchers returning to Israel from outside of Europe, based on the principal that Israel should enjoy all the rights enjoyed by the Member States of the European Union, which by means of this programme encourages European researchers to return to their homelands. As aforementioned, the main role of the Ministry of Science and Technology is to preserve, foster and develop the existing knowledge base in Israel in order to ensure the its future in the coming decades. The Ministry’s flagship programme is the scientific infrastructures programme which encourages inter-disciplinary, multi-disciplinary and inter-university research with high levels of feasibility for industrial growth. This program represents a bridge between basic academic research and industrial development and minimizes the ripening period of useful technological ideas. In this regards there is an important place for the integration of Israel into the European Framework Programme. Israel’s successful integration into the European Framework Program is a remarkable achievement, intended for positive influence for the advancement of science, the industrial ties with European States, for the transfer of technology and Israel’s status as a leading scientific-technological player in the international arena, particularly in the European arena. I would like to bless all those who are involved, and wish us all that we will succeed in going on making the best in the programme to leverage the power of Israeli science. Rabbi Professor Daniel Hershkowitz Minister of Science and Technology 5 13 Bar Mitzvah Bar Mitzvah Greetings from the Commissioner for Science and Research At the end of 2006, I expressed my hope in this publication that the positive past experience would motivate Israel to further boost the momentum for its participation in FP7. Today, three years later and close to middle of the lifetime of FP7, I am happy to say that my hopes have been become reality! Israel's success is continuing under FP7. This is remarkable since the increase in the number of Member States and of Associated Countries, as well as the general opening of the FP to international participation, have led to much tougher competition for participation and funding. The scientific excellence and flexibility of Israeli researchers and enterprises have helped in adapting to these new conditions as well as to the new instruments created under FP7. Thus, for example Israel's participation in recent European Research Council calls, which fund investor-driven frontier research, has been outstanding. Beyond Israel's continued strong involvement in the Framework Programmes one should not forget the other important elements which mark the intensive Science and Technology (S&T) cooperation between Israel and the EU: Israel is a full member of EUREKA and since 2005, through Matimop, participates in the Galileo Joint Undertaking, the European satellite navigation programme. Ten EU Member States have concluded S&T cooperation agreements or arrangements with Israel. Furthermore, Israel is, as an associated country, actively involved in the further development of the European Research Area. ERA is establishing a zone in which researchers, scientific knowledge and technology can circulate freely. I am confident that the EU-Israel S&T partnership will further contribute to solving global challenges, such as climate change and dangerous diseases, and that it will create links between people and thus be an important building block for the further development of good overall EU-Israel relationships. Yours sincerely, Janez Potocnik European Commissioner for Science and Research Bar Mitzvah Bar Mitzvah We are currently celebrating 13 years since Israel joined the European Framework Programme. Although compared to history this is a short period of time, we can look back upon it with pride and satisfaction. The participation of the Israeli academia in the programme has proved itself to be a significant and prominent one and has yielded substantial success rates. The analysis of the results of the calls for proposals within the currently ongoing Seventh Programme alone, shows that the rate of winnings in the academic sector, stands at more than 50% of the total wins. More than 30 young Israeli researchers have won the programmes’ funds during the last two years and proved that Israeli research and excellence have a bright future. The Israeli academia is putting in significant, daily efforts to strengthen the collaborations with industry, on both national and international levels. Despite that fact that most of its role is basic research, according to the researcher’s will, which stems from the academic freedom the Israeli academia is blessed with, every fitting academic institution has a commercializing company whose role is to identify, locate and leverage the relevant basic research with the aim of realizing it into a commercial and industrial products. In this sense, there is significant importance in the Israeli academia’s participation in the European Framework Programme as an additional channel to transfer technology and leverage the knowledge collected within the walls of the academia, all the while translating it into realizable projects. The European Union decided to place Europe in a leading position in scientific research. In this regard it is important to note that the Seventh Framework Programme established the European Research Council (ERC) through which it runs a competition regarding excellence in technological innovation on a European level. Here, grants are awarded to ground breaking researchers. So far 58 Israeli researchers have been awarded these grants, totaling over 70 million Euros. These wins place Israel in the leading position in Europe relative to the number of researchers in the country. In addition, within “People” programme the ‘International Reintegration Grant’ enables Israel to reabsorb Israeli researchers working in the United States and to integrate them into the academic research in Israel. The participation of the Israeli academic institutions in the Framework Programme, since the Fourth Programme, has not always been easy and was accompanied by a number of obstacles. However, over time and with a constant learning process, Israel’s status improved and the Israeli academia succeeded in leveraging Israeli participation in the European Programme and to maximize its yield. Participation in a multi-national European programmes enables scientists and researchers access to large research facilities, along with their integration into large international scientific partnerships which are not always readily available under normal conditions. This provides Israeli institutions of higher education the opportunity to express their abilities and to realize their potential for the benefit of society and the economy. Much has been said about the return on the Israeli investment in the European Framework Programme. In the beginning doubts were still voiced regarding the return Israel was getting for the funds it contributed to the Programme. It seems to me that today no one doubts that Israel has indeed returned its investment and with significant yield. For the Israeli academia, this means direct research grants for Israeli scientists and scientifictechnological-industrial partnerships at monetary scopes which exceed by far the original investment. Israeli sciences in general and particularly Israeli scientists are highly esteemed around the world. The Nobel Prizes Israeli scientists have been awarded in recent years bear witness to this. We must continue to invest in the development of the basic and applied research in Israel to ensure the might and power of Israeli society despite the challenges of the 21st century. The Israeli participation in the European Framework Programme is a significant factor in the achievement of this goal and we should put in national efforts to ensure the continuation of this praiseworthy partnership and intensify it. Sincerely, Professor Manuel Trachtenberg Chairman of the Council for Planning and Budgeting, the Council for Higher Education 5 6 13 In honor of the "Bar Mitzvah" of Israel's joining the European R&D Programme, it is important to highlight the significance of its participation in these programmes. The scope of the investment in civilian R&D as a measure of Israel's outcome stands at 4.5%, a figure which places Israel at the global top in the field of research and development. Israel is also a leader Photo: Ofer Vaaknin regarding the scope of technological manpower, in addition, in the field of patents, Israel has substantial achievements, while being a global leader for the rate of patents in the field of medical equipment and has positioned itself in fifth place in the rate of patents per person. These are but a few examples of a variety of impressive data, particularly for a small country, numbers to be proud of. But we shouldn't rest on our laurels. We live in a dynamic global reality, the competition is fierce and many countries are catching up and quickly. A prominent example is South Korea that has leapt forward in the last decade. It is important to note that Israel's main asset – its manpower – necessitates non-stop investment and care. This is a critical investment for our future as a society and a country. Israel already possesses the infrastructure and potential to improve its economic situation and its global positioning. To succeed, it is necessary to increase the investment in science and technology. These investments represent a fantastic driving force for growth, and are necessary particularly due to the global recovery and the increased competitiveness. The European Framework Programme, which we are currently celebrating 13 years of Israeli association, has represented throughout these years a remarkably important means for the advancement of collaboration in the field of R&D between industrial companies and academic institutions in Israel and their colleagues in Europe. The latter enabled Israeli companies from all fields and of all levels – from startups to large corporations – to develop, expand their knowledge, their abilities and capital as well as assist in their development, as part of the impressive expansion in the Israeli market over the last decade. For the academia, the Programme offers a significant platform for development and scientific excellence. The Seventh Programme (FP7) is larger and more ambitious than its predecessors. In fact, this programme as well as other programmes which were developed within the European Union, are leading a significant step whose purpose is doubling the European investment in research and development. The Seventh Programme, which will continue until 2013, deals with, amongst others, the fields of communication, nanotechnology, biotechnology, software, agriculture, energy, space and security. Israel's industries and research institutions have a significant competitive advantage in all of these fields. The collaboration with the academia and corporations in Europe are likely to assist in the advancement of Israel's abilities in these fields. Being part of the programme allows the Israeli academia and industry to integrate into the most advanced R&D programmes in the world, to be exposed to knowledge that is pertinent for the advancement of science and industry and to be positioned at the forefront of global technology. Thanks to the ties and collaboration in R&D created through the Programme's activities, new markets have opened up for Israeli companies' products and significant business opportunities have been created. In addition, participation in the Framework Programme strengthens the industrial and academic ties with Europe, while providing access to large research budgets, innovative knowledge and business intelligence. Currently the Seventh Programme is a significant source of funding for many researchers in the Israeli academia. It is worth mentioning that the benefit to the State of Israel is not measured solely through direct financial return, rather through the participation of the Israeli R&D community in research whose scope is billions of Euros. The research and development, the information and knowledge that Israeli researchers are exposed to, along with the ties built with the European Union and the industrialized countries within it, create an important strategic partnership for Israel. Dr. Eli Opper Chief Scientist Ministry of Industry, Trade and Labor Chairman of ISERD's Steering Committee Israel's Results in FP7 - November 2009 Israel's contribution to FP7 so far: 160 M€ Submitted Participations 3446 Successful Participations 698 Success by sector: Industry 152 University 426 Others 120 Submitted Proposals 2446 Successful Proposals 247 Success Rate Value of Israeli grants: 243 M€ 20.3% Industry 71 M€ University 154 M€ Others 18 M€ Overall value of projects with at least one Israeli partner 3.4 B€ Overall value of projects with at least one Israeli Industrial partner 1.3 B€ Source: ISERD Database 6 Bar Mitzvah Bar Mitzvah The Gateway to Europe Joel Tsafrir "Participating in the European Framework Programme grants Israeli companies access to knowledge and information that leverages the value of the project and the scope of the exposure", says Marcel Shaton, General Manager of ISERD, the Israel-Europe R&D Directorate, that promotes the participation of Israeli entities in projects within the European Framework Programme In the Jewish tradition, age 13 demarcates the Bar Mitzvah ceremony. If you like, it is a Jewish membership ceremony. Differentiating between childhood and maturity, and expresses the transformation of a child into an adult from a Jewish Law point of view, something which allows and even obligates him to perform the entire commandment (Mitzvahs). Why are we reminded of this? Because Israel is currently celebrating 13 years since it joined the European Framework Programme, whose goal was to promote cooperation in the field of research & development between the continent's countries. In a number of aspects this milestone is also a symbolic one, since after a modest and hesitant beginning, which has become a strategic project for Israel, when academic institutions and business companies found a uniquely important channel for crossborder cooperation, funding, investments and the advancement of financial initiatives and projects on growing scales. For the Israeli academia, for example, the Programme has become a source of funding comparative in size with the research budget of the National Science Fund. Israel joined the European Framework Programme in 1996. It is important to note that those days were the post-Oslo days of euphoria, when as gesture of goodwill and as recognition of its scientific status Israel was added to the Framework Programme with the status, of associated country. Israel began participating in the Programme, in practice, during the Fourth Framework Programme. Despite being defined as an accompanying partner, Israel enjoys all the rights of a member state and it is actually the only sphere in Europe where Israel enjoys all the rights provided to the Member States of the European Union. What began as a political gesture quickly became clear to both parties as a worthwhile transaction. Israel, thanks to the large investment in civil R&D and with excellent manpower in the fields of engineering, biotechnology and HiTech, was quickly seen as worthy member and wanted partner in the Programme. On their part, the Israelis throughout the years, got to know the Programme's advantages, and all its layers. It's true that the Programme necessitates the direct flow of Photo: Ziv Sade 13 Bar Mitzvah Bar Mitzvah the extent of 167 million Euros. Therefore, the debate regarding the Sixth Programme was much simpler. Israel transferred over 191 million Euros and received 204 million Euros. In the current Programme – the seventh, so far Israel has transferred 160 million Euros and has received 243 million Euros. The total payment that Israel "For Israeli companies the R&D is a huge opportunity to acquire knowledge and create long term ties and not just a channel for funding in the short term. This is due to the fact that the research takes place in close cooperation with a number of factors" government funding to the shared coffer, but the return received at the end of the day is bigger and more significant. At the beginning, Israel transferred over 100 million Euros to the Programme and received only 50 million Euros in return, something which led a number of public bodies in Israel to fear that there was no financial feasibility in the Programme. As time passed, the balance sheet changed. During the Fifth Programme, Israel transferred over 154 million Euros and received research funding to will transfer to the Framework Programme by 2013 is estimated at half a billion Euros. "Despite the financial data which is attractive on its own, the quantitative aspect is not everything," claims Marcel Shaton, the General Manager of ISERD, the Israeli Diractorate for the European Framework Programme for Research and Development, which is responsible for the implementation of the Programme in Israel. "For Israeli companies the participation in 7 8 13 the Framework Programme opens a range of opportunities to acquire knowledge and create long term ties and not just a channel for funding in the short term. This is due to the fact that the research takes place in close cooperation with a number of factors. Most of the companies enjoy a flow of knowledge which goes beyond the cash flow in importance. So far, in the Seventh Programme, the projects with at least one Israeli industrial company's participation are valued at 1.3 billion Euros. According to conservative estimations at least one third of this sum is the value of the knowledge utilized by the Israeli industry. "Take Peptor for example – an Israeli biotechnology company, not too big, which develops a certain molecule. Peptor, and this is a real story from the field, only received 30,000 Euros in funding, but actually saved 1.8 million Euros in clinical research which it intended to carry out anyway. In addition, try to imagine the amount of knowledge, connections and reputation it accumulated from its participation in the Programme. The Israeli Company Compugen was the coordinator of a consortium which built gene data banks, which had it wanted to establish alone would have had to fund it by itself. Therefore the company saved impressive budgets and resources. It is important to think in these terms and not in terms of cash flow alone. This is a powerful leverage." Science and Industry Ties Israel's acceptance as an associated member into the European Framework Programme is still considered to be one of Israeli diplomacy's biggest achievements. After all, Israel is the only country, other than Switzerland, which isn’t a member state or candidate country of the European Union, which has earned this status. This has significant value for Israeli science and technology which influences on science itself, on industry ties with Europe, including technology transfer, regarding the enhancing of Israel's international status as well as attracting R&D investments to Israel. Israel is becoming attractive to foreign investments in the field of R&D as the R&D units found in Israel qualify for European funding from the Framework Programme. This explains the widespread activities of companies such as IBM, Microsoft, SAP's first steps and Intel's new initiatives. To translate the success of diplomacy into practice ISERD was founded – the Israeli Directorate for the European Union Framework Programme for Research and Development. ISERD's actions are led by an inter-ministerial steering committee headed by the Chief Scientist of the Ministry of Industry, Trade and Labor, Dr. 8 Eli Opper, and whose partners are the Ministry of Industry, Trade and Labor, the Ministry of Science and Technology, the Foreign Ministry and the Ministry of Finance, as well as a representative of the Planning and Budgeting Committee of the Council for Higher Education, responsible for academic research funding through the National Science Fund. ISERD's General Manager, Marcel Shaton, is the spirit behind the programme in Israel. Shaton, a former Minister for Economic Affairs in Brussels, has been active for many years in the Ministry of Industry, Trade and Labor as well as in the field of foreign trade. As someone who came from the hallways of the EU in Brussels, he is considered to be one of the most important and prominent experts in the field of commercial and diplomatic ties with Europe. What is ISERD's main mission in your opinion? "Our mission is twofold: to strengthen Israel's integration into the European research area and to create a support infrastructure and an array of activities to take full advantage of the European R&D Programmes. If you will, we are ambassadors of the Israeli industry and "We work both to advance Israel's matters with the European Commission, and we make sure the funding programmes and the projects will match Israel's case, as well as serve as liaison officers in all the sub-programmes of the Seventh Programme" academia in the European Commission and ambassadors of the European Union amidst these factors here. We work both to advance Israel's matters with the European Commission, we make sure the funding programmes and the projects will match Israel's case as well as serve as liaison officers in all the sub-programmes of the Seventh Programme". What are the benefits to Israeli factors considering joining the Programme? "There is a wide variety of benefits, and it is my opinion that the most important one is the access to the European market. I like to call it the "gateway to Europe", or the "highway to Europe." We're talking about a huge market of knowledge, services, capital and budgets, as well as a huge human expanse with 500 million residents, and a number of new markets with its borders. In my opinion, this is an important component in the age of globalized markets. We are geographically and culturally close to Europe and we should be taking advantage of this as much as possible. Within the Framework Programme, unique tools are provided to realize the potential of this proximity. The proximity to Europe allows us as Israelis to learn as well as understand the ways things are run and the European way of thinking which is a pertinent component in today's business world. The acquaintance with clients, suppliers and competitors, across the continent, provides the factors in Israel with business intelligence in an exceptional quantity and quality, through widespread exposure, particularly partnerships for innovative technologies, as well as involvement in the design of new standards, which possess 9 13 Bar Mitzvah deep financial significance. Getting to know and understanding the industrial, technological and social processes has added value which is no less important that the direct economic benefit. The ability to be a part of a pan-European network also has considerable value, particularly for a small country. Meaning, the ability to enjoy participation in large projects, rich in vision, all the while being granted financial grants without having to relinquish any intellectual property. In short, this is a significant leveraging opportunity for the Israeli companies and academia. I see significant importance in cooperating with the Israeli industry and academia as well as the entire local R&D community in the European Research Area, which provides the opportunity to break out of the local market and into a large global powerful multidimensional market." What does the Seventh Programme focuses on? "The Programme's structure includes four main fields: Cooperation, between different research organizations in different countries with the aim of achieving a leading position in a scientific or technological field. We're talking about fields such as health, agriculture, energy, communications, environment, transportation, space, security and more. This field makes up 64% of the Programme's budget. An additional field: Ideas, whose goal is to encourage and support new ideas and basic research in all fields, it makes up 15% of the budget. In the field of People the intention is to strengthen the human capital in the fields of research and technology, including training, career development, strengthening science-industry ties and more. This field makes up 11% of the budget. And the final field: Capacities which deals with research infrastructure, research for small and medium size enterprises (SME's), science in society, international cooperation and more, with 8% of the budget allocated." Are there specific fields which may be of particular interest to Israelis? "In my opinion, Israeli companies and academia may find a significant interest in most of the fields. The numerous and various fields include health, with an emphasis on biotechnology, food and agriculture, information and communications, nanotechnology, energy, with an emphasis on alternative and renewable energy, the environment, space and security. Israel is considered a prominent player who holds an advantage position in all these fields in the international arena and is likely to enjoy research grants and participation in consortiums which will clarify Israel's relative advantage in the European market." Bar Mitzvah Bar Mitzvah Bar Mitzvah Which figures regarding the Israeli participation in the Seventh Programme can you present already? "By analyzing the calls for proposals in the Seventh Programme from the start and up until November 2009, it seems that the number of participants stands at 3,446 and the number of successes at 698. An analysis of the success rate by sectors shows that the industry registered 152 successes, 426 successes for the universities and 120 for other factors, meaning a 20% success rate. Regarding research grants, Israeli organizations received 243 million Euros of which the industry received 71, the academia 154 and other organizations received 18 million Euros. It is important to mention that regarding industry, added onto this is the value of knowledge made available which is measured to be at least 400 million Euro. The Programme emphasizes large projects. Do the latter prevent the participation of small and medium size enterprises? "Definitely not. We are talking about large-scale projects, but the consortiums' are composed of numerous actors, part of which are likely to be small and medium size enterprises. Actually, Europe encourages this. We too, here in Israel, have established a support fund for small and medium sized enterprises which helps these companies submit proposals to the Seventh Framework Programme. The goal is to encourage small and medium sized enterprises to participate in the calls for proposals, through funding assistance, in the search for other partners in Europe and for tie-building with them." Strengthening of European Integration "The main goal of the European Framework Programme was to strengthen the European integration process" says Marcel Shaton, ISERD's General Manager. "You can call it an additional tool in the pan-European effort to overcome the national instinct in exchange for the European entity, with the aim of advancing cross-border cooperation between scientists, researchers and academics from different countries, as a way to advance economic and social projects. The idea is to create a mechanism which will represent a framework which promotes the existence of joint projects between Germans, the French, Swedes, Italians and so on. The process is carried out through the publication of calls for proposals in the different fields of R&D and creating joint consortiums with the participation of entrepreneurs, researchers, people from industry and academia, as well as different organizations from different nationalities and countries. The multi-player consortium is a central tool which translates the idea of cooperation into practice, incorporating within it factors from a number of countries and sectors within the countries." At the beginning, Shaton explains, the Programme was run according to cooperation lines similar to those customary in the academia, but over time a correct and desirable balance was achieved on the academia-industry axis and the Programme became one of the most important factor in the European economy which connects between two interfaces. The Programme also moved from a four-year budget to a seven-year budget, which increased the ability to plan in the long term as well as the budgets and resources which were made available to the Programme. If between 1984 and 1987 the Framework Programme's budget stood at 3.3 billion Euros, today the budget for 2007-1013 stands at no less than 49 billion Euros. In recent years, the growth stems from other states joining the Programme due to the expansion of the European Union. In general, the Seventh Programme has set the bar higher in all aspects and is considered not just the longest and most expensive, but rather also the most ambitious Programme of all its predecessors. The Seventh Programme also launched a new panEuropean competition designated for individual researchers to fund groundbreaking research and by this create the "European Nobel Prize Winners Reserves". Israel particularly excels in this programme with 58 wins totaling over 80 million Euros. In addition to the political goal of advancing European integration, the Programme's designers saw additional goals, such as the increase in capacity for competitiveness of the European economy, particularly vis-a-vis the creation of large trade blocs in the world and the rise of economic superpowers such as China and India, job creation and improvements in quality of life, while solving problems with economic and social significance. The Seventh Framework Programme includes 27 member states and an additional 11 states that are not members but that are in some sort of proximity to Europe. This is part of the process of getting closer and good neighbors' attitude defined as one of Europe central goals in the era of globalization and inter-bloc competition on the economic level. 9 *4&3% Your Port To FP7 In ISRAEL FP7 is r o f e l The ru ELLENCE EXC for a g n i k Loo TNER? PAR ne in o d n i F L ISRAE Winners from the Israeli Industry Acktar Ltd. Afcon Software and Electronics Ltd. Algatechnologies (1998) Ltd. Alpha Omega Engineering Ltd. Alvarion Ltd. - coordinator Applied Spectral Imaging Ltd. Argad Ltd. BandWD Ltd. Baruty & Sons Ltd. Better place Browzwear international Ltd. (Israel) Correlation Systems Ltd. Elbit Systems Ltd. – 3 projects Environmental & Water Resources Engineering Exent Technologies Ltd. - coordinator FamCorner Ltd. - 2 projects Freshpoint Ltd. Hanita Coatings Ltd. IBM Israel Ltd. – coordinator, 8 projects Idea Bio-Medical Ltd. - 2 projects ImageSat Israel Ltd. Intel Electronics Ltd. Israel Aerospace Industries Ltd. – 5 projects Israel Airports Authority Israel Electric Corporation Ltd. - 3 projects Kaltura, Inc. Lapidoth Israel Oil Prospectors Corp. Ltd. LiveU Ltd. MedInvest Holding Microsoft Israel R&D (2002) Ltd. Motorola Israel Ltd. - 2 projects NanoMaterials Ltd. Israel Nevet Nicast Ltd. - coordinator Optibase Ltd. - 3 projects Orbotech Ltd. Orckit-Corrigent Ltd - coordinator Ltd. - coordinator Ortholine Ltd. Prochon Biotech Ltd. Dr. Raz Zarivach Interdisciplinary Center (IDC) Herzliya Dr. Doron Friedman Dr. Sarit Markovich Ort Braude College of Engineering Dr. Judith Abrahami Technion - Israel Institute of Technology Prof. Hagit Attiya Prof. Gad Bahir Dr. Ayelet Baram-Tsabari Prof. Jacob Bear Dr. Eli Ben-Sasson Dr. Sonia Berrih Aknin Dr. Zeev Bomzon Dr. Eyal Buks Dr. Yacov Crammer Mr. Mark Davison Dr. David Gershoni Prof. Boaz Golani Prof. Shalom Hakkert Prof. Amnon Harel Prof. Yael Herer Dr. Ehud Keinan Dr. Kinneret Keren Dr. Estee Kurant Dr. Shulamit Levenberg Prof. Efrat Lifshitz - 2 projects Dr. Shie Manor Prof. Avi Marmur Prof. Ariel Miller Prof. Uriel Orda Prof. Miriam Reiner Prof. Uriel G. Rothblum Dr. Sigal Savaldi-Goldstein Prof. Assaf Schucter Prof. Mordechai Segev Prof. Dov Sherman Dr. Ariel Stanhill Prof. Yeshayahu Talmon Prof. Nir Tessler Born Dr. Itay Fischhendler - 2 projects Dr. Igal Galili Dr. Nir Halman Prof. Sergiu Hart Prof. Joseph Hirschberg Dr. Adi Inbal Dr. Sebastian Kadener Prof. David Kazhdan Prof. Bianca Kühnel Prof. Alexander Levitzki Prof. Aaron Lewis Prof. Shlomo Magdassi Dr. Eran Meshorer Dr. Yaakov Nahmias - 2 projects Prof. Eran Razin Prof. Aner Shalev Dr. Eran Sharon Prof. Roy Shinar Dr. Jake Solomon Dr. Daniel Strasser Prof. Albert Taraboulos Dr. Edit Tshuva Goldberg Prof. Itamar Willner The Open University of Israel Prof. Miriam Souroujon University of Haifa Dr. Ayelet Ben-Sasson Dr. Amit Bernstein Dr. Anat Prior Unger Prof. Kobi Rosenblum Weizmann Institute of Science Prof. Uri Alon Prof. David Cahen Prof. Milstein David Dr. Barak Dayan Prof. Irit Dinur Dr. Michael Epstein Prof. Zelig Eshhar Prof. Tamar Flash Prof. Lucio Frydman ISERD’s Steering Committee Chaired by Dr. Eli Opper Chief Scientist of the Israeli Ministry of Industry, Trade and Labor Marcel Shaton, General Manager of ISERD and ISERD’s Team Congratulate the 258 outstanding companies and researchers for their winning of EU FP7 research grants in the passing year: The Israel-Europe R&D Directorate For EU FP Council for Higher Education Planning&Budgeting Committee Ministry of Science & Technology ת Office of the Chief Scientist Ministry of Industry Trade & Labor 03-5118122 Registration at: )PMETXFFLMZ 0SJFOUBUJPO 1SFTFOUBUJPOT PO&6'1 www.iserd.org.il Dr. Itai Yanai Dr. Dvir Yelin Dr. Shaked Yuval Dr. Lihi Zelnik-Manor Prof. Noam Ziv Prof. Yoram Zvirin Tel Aviv University Prof. Niv Ahituv Prof. Eddie Aronovich Dr. Yaniv Assaf - coordinator Prof. Eyal Ben-Dor Dr. Michael Birnhak - ICTAF Prof. Reuven Boxman Dr. Haim Diamant Prof. Tommy Dreyfus Dr. Micha Fridman Prof. Menachem Goren Prof. Dagan Hanoch Dr. Tali Hatuka Dr. Anat Hershkovits Dr. Oded Hod Dr. Tali Kaufman Dr. Boaz Klartbag Prof. Michael Kozlov Prof. Abraham Kribus Prof. Yishay Mansour Dr. Uri Nevo Prof. Abraham Nitzan Dr. Itzhak Omer Dr. Dan Peer Dr. Yael Roichman Prof. Michael Romann Dr. Alon Savidor Dr. Hila Shamir Dr. Yair Sharan - coordinator - ICTAF 2 projects Dr. Carmit Tadmor Prof. Hezy Yeshurun The Inter-University Computation Center – IUCC - “MACHBA“ Mr. Moshe Gottlieb Dr. Henry Nussbacher The Hebrew University of Jerusalem Dr. Knafo Ariel Prof. Yechezkel Barenholz Prof. Shimshon Belkin Dr. Noam Berger Dr. Liram Carmel Dr. Ehud Cohen Dr. Yuval Dor Dr. Shabtay Dover Dr. Leor Eshed Williams Mrs. Pnina Feldman Dr. Daniel Felsenstein Winners from other Sectors Agricultural Research Organization (Volcani) - 2 projects ARTTIC Israel - Halevi Dweck & co. - 2 projects Association for Medicine and Research in Galilee Beacon Tech Ltd. - 2 projects Bloomfield Science Museum - 2 projects Clalit Health Services Edna Pasher, Phd.&Associates - coordinator Ernst &Young-Israel Euro-Consultants Ltd. Geological survey of Israel Geophysical Institute of Israel Hadassah Medical Organization - 2 projects Intergam Communications Ltd. Israel Antiquities Authority Israel Association of Electronics & Software Industries Israel Oceanographic & Limnological Research Ltd. (IOLR) - 2 projects Maccabi Healthcare Services - 2 projects Mada Tech- Israel National Museum of Science, Technology & Space MAKASH - Advancing CMC Applications in Education, Culture and Science Migal-Galilee Technology Center- coordinator, 2 projects Ministry of Agriculture and Rural Development - 2 projects Ministry of Science, Culture and Sport Or Yarok Osm-Dan Ltd. - 2 projects Tel-Aviv Sourasky Medical Center - 2 projects The Chaim Sheba Medical Center - 3 projects The International Security and Counter - Terrorism Academy - ISCA Prof. Yuval Gefen Prof. Benny Geiger - 3 projects Dr. Lilach Gilboa Dr. Shahal Ilani Prof. Klein Jacob Dr. Tali Kimchi Dr. Rafal Klajn Prof. Doron Lancet - 2 projects Dr. Sharon Michal Prof. David Milstein Dr. Elchanan Mossel Prof. Nir Orion Dr. Zvi Paltiel Dr. Rony Paz Dr. Gilad Perez Prof. Uri Pick Prof. Itamar Procaccia Prof. Omri Moshe Sari g Dr. Oren Schuldiner Dr. Maya Schuldiner Prof. Michal Schwartz Prof. Reshef Tenne Dr. Assaf Vardi Industry House, 29 Hamered St. Tel-Aviv Tel: +972-3-5118118 Fax: +972-3 -5170020 [email protected] Winners from the Israeli Academia Academic College of Tel Aviv - Jaffa Dr. Merav Zion-Cohen Bar Ilan University Dr. Michal Ben-Shachar Dr. Ofer Bergman Dr. Miriam Bitton Dr. Haim Cohen Mrs. Shoshana De la Fuente Dr. Sol Efroni Dr. Maoz Fine Prof. Aharon Gedanken - coordinator, 2 projects Prof. Joseph Glicksohn Dr. Miri Goldin Dr. Yehuda Lindell Dr. Israel Isser Peer Dr. Avi Peer Prof. Jonathan Rabinovich - coordinator Dr. Sven Ruhle Dr. Orit Shefi Dr. Shlomo Shpiro - coordinator Ben-Gurion University of the Negev Prof. Miriam Amit Prof. Sammi Boussiba , 2 projects Dr. Ron Dabora Dr. Opher Donchin Prof. Yael Edan, 2 projects Prof. Moshe Gottlieb Prof. Moti Herskowitz Dr. Robert Marks Dr. Ohad Medalia Dr. Michael Meijler Dr. Haim Permuter Dr. Oren Rigbi Dr. Maoz Shamir Dr. Ilya Tyomkin Procore Ltd. Pronto Diagnostics Ltd. Protein Production Services Ltd. RAD Data Communications Ltd. Rafael Advanced Defense Systems Ltd. - 2 projects Raicol Crystals Ltd. Rotem Industries Ltd. Saliwell Ltd. - 2 projects SAP Israel Siemens PLM Software Ltd. Siklu Communications Ltd. Teva Pharmaceutical Industries Ltd. Verint Systems Ltd. - coordinator - 2 projects Yitran Communications Ltd. Yodfat Engineers (1994) Ltd. 12 12 13 A Bouquet of Israeli Success Joel Tsafrir Designing Europe's future communications network architecture, managing large-scale disasters, developing target oriented medicines for cancer, minimal-invasive surgeries using robots, rehabilitation of ground water, genetic enhancement to increase crops and teaching nanotechnology to youth – these are but a few of the European projects Israeli industrial companies, universities and other organizations have participated in as part of the Seventh Framework Programme for Research and Development. Here we present a selection of projects with Israeli participants who have been granted funding which represent the competitive advantage of the Israeli R&D Designing Europe's Future Communication Network A Support System for Decision-Makers in Emergencies ETNA Project ESS Project Israeli partners: Nokia Simmons Israel – Coordinator; Ethos Networks; Ben-Gurion University in the Negev; Ernst & Young Israel Prominent partner: British Telecom; Nokia Simmons, Germany Budget: 3.4 million Euros ETNA is a key project for developing efficient architecture for the internal European Network. This architecture will be able to serve millions of subscribers, with high and credible transport quality while supplying different network services, some of which are already in use today, while others are planned to be developed in the future. The successful construction of these architecture networks such as this will help the future design of knowledge and communication technologies and will provide a variety of new opportunities for the creation of value added products and services. One of the project's goals is to find a solution wherein infrastructure providers will be able to supply services at a wide geographical range, through coordination and connectivity between the cross-border communication services in Europe. Israeli partners: Verint Israel; Aeronautics; Magen David Adom Israel; Ernst & Young Israel Prominent partner: Alcatel-Lucent Italia Budget: 14.5 million Euros The Emergency Support System (ESS) project's core combines the application and use of information technologies in real-time and it's meant to provide information to decision-makers to allow for the educated management of crises and irregular events such as stadium evacuation, forest fires, leakage from nuclear reactors, accidents at toxic waste dumps and others. Decision-makers are often required to make decisions in a short period of time and information from the field is critical. Using a lifesaving system to manage and control the event, through the real-time synchronization of ground forces (police, rescues and firefighters) and from scene supervision and control centers. The approach guiding the project is based on channeling the details received from the field to the central system which will provide the information analysis and support applications in the decision-making process. The project strives to improve data assembly technology (radioactive, biochemical, audio-video and so on) to be installed on mobile and fixed platforms, and will supply flexible, yet complete, coverage of the contaminated area while reducing the uncertainty which characterizes emergencies. Health Risk Prediction & Management GAP Project Israeli partners: The Israeli Ministry of Health; Macabbi Health Services Prominent partners: The Spanish Ministry of Health; The National Institute for Health Research, France Budget: 1.3 million Euros Swine Flu, which is currently sweeping through the world, is an example of the need to manage health crises which are today befalling the global arena. These crises necessitate advanced organization, danger identification and preparing the plans and the tools needed for government and intergovernment intervention at times of crisis. This project tests the entire spectrum of calculating, preparation and managing risks in the field of health, while creating the tools which will allow for intervention in real-time crises. The project will evaluate all of the contemporary and future solutions for health crises, with the aim of assisting decision-makers in managing them while being provided with assistance from computerized tools to gather and broadcast information. . The challenge is to construct a genuine system to manage health crises and social protection and its components on a European and global level. Designing the First Responder Reaction to Large-Scale Disasters NMFRDisaster Project Israeli partner: Magen David Adom Prominent partners: Ambulance Services, Holland; Red Cross of Spain and Denmark; The Centre for Science, Society and Citizenship, Italy; AlQuds University, West Bank (and Gaza strip) Budget: 815,000 Euros Identifying the Needs of Medical First Responder in Disasters (NMFRDisaster) is critical. It requires the immediate reaction of a skilled team, this project intends to examine needs of the medical first responders in disasters, such as those of emergency and rescue teams. The project, which includes discourse between medical first responders and research institutes, has made it its goal to identify and chart the needs and pave the 13 13 Bar Mitzvah Bar Mitzvah Bar Mitzvah way for additional research in fields such as training methods, understanding the human toll of disasters on first-responders, examining the ethical and legal issues, identifying the personal protective equipment necessary in chemical and biological events and utilizing blood and blood products in large-scale disasters. Limiting Infections in Hospitals SONO Project Israeli partners: Bar-Ilan University; OSM-DAN; Afcon Software Electronics Prominent partners: Coventry University, UK; Catalonia Polytechnic, Spain Budget: 12 million Euros This is a large-scale integrative project which combines medical, financial and technological matters. The rationale is the prevention, or the reduction, of hospital-acquired (nosocomial) infections, a financially significant subject in the European health system. These kinds of infections have many negative effects, as they neutralize medical treatment, including the most advanced care, and make hospitalization more expensive due to its extended period (an average of 8 days for infected patients). The statistical data points to the fact that 1 of 10 patients is infected with hospital-acquired infections and that 3 million deaths are caused by hospital-acquired infections. The project is intended to develop an array of durable antibacterial medical textiles. We are currently referring to a pilot line, based on a patent-protected sonochemical process, developed in of Bar-Ilan University's laboratories. The pilot is intended to create inorganic, antimicrobial nano-particles on medical textiles such as hospital sheets, lab coats and bandages. A Robotic Shoe to Prevent Falls Amongst the Elderly SMILING Project Israeli partners: Step of Mind; Mishan Center Prominent partner: The Polytechnic Federal School, Lausanne, Switzerland Budget: 3 million Euros Due to changes in the sensory, neurological and musculoskeletal systems as a result of aging, healthy elderly people suffer from severe falls which may limit their mobility. This population groups varies, with almost every third person aged 65 and older and every second person aged 75 and older suffers from this problem. The project's goal is to prevent falls and to improve mobility through a robotic shoe. The project uses chaos theory and dynamic systems theory to create a shoe to be worn on the individual's feet and allow for small alterations in steps according to the environment, the shoe will assist in overcoming the phenomenon and the rehabilitation of the neurological areas responsible for walking. Objective Oriented Medication NANOPORATION Project Israeli partners: InSightec; CapsuTech Prominent partner: University of Dundee, UK Budget: 2 million Euros The field of drug delivery is one of the hottest in today's world of pharmaceutics. The medicine is capable of directly reaching the limb in question, therefore increasing its effectiveness, while minimizing the damage to the limb's environment. This project, which combines clinical, industrial and academic expertise, makes use of a number of the most advanced technologies to create a capsule coating which will deliver active cancer-fighting medication directly to the malignant tumor. Remote release of medication through external targeted ultrasound energy and the use of MRI technologies will enable a heightened absorption of medicine and intervention in the delivery of medication in the body by imaging. Bar Mitzvah Rehabilitation and Purification of Ground-water AQUAREHAB Project Israeli partner: Ben-Gurion University of the Negev Prominent partners: UNESCO; The Flemish Institute for Technological Research, Belgium; Leuven Catholic University, Belgium; Delft Technology University, Holland Budget: 9.25 million Water treatment is one of the world's central issues today due to the lack of water in general and the severe lack in potable water in particular. The project's goal is to develop innovative rehabilitative technologies for soil, groundwater and surface water, which have been polluted by hazardous material (Nitrogen compounds, pesticides, chemical compounds). The technology is meant to be used in seashore areas. Among the innovative aspects of the project are smart biomass containing carriers for treatment of water in open trenches; in-situ technologies to restore degraded surface water by inhibiting influx of pollutants from groundwater to surface water; multifunctional permeable barriers and injectable Fe-based particles for rehabilitation of groundwater. One of this project's main results will be an aquifer management tool which integrates multiples measures with ecological and economic impact assessments of the whole water system. A Revolution in Archeological Research RAIELSP Project - ERC programme Winning researcher: Professor Israel Finkelstein, Tel Aviv University Budget: 2.9 million Euros The study of antique biblical texts, along with research of material culture, was the pillar of European study since the enlightenment. Today, conventional research has reached a dead end. Part of the problem stems from the fact that the biblical testimony was written long after the events described took place, as well as the fact that the writers and researchers had a theological agenda. Exact and life sciences research methods are not limited by the same prejudices and can expose information which isn't apparent. The innovation in this project lies in action within ten different research tracks borrowed from the life and exact sciences in order to better understand ancient Israel, while using advanced methods in the fields of genetics, mathematics, chemistry and archeozoology. The Next Cellular Revolution – A User-Centric Paradigm PERIMETER Project Israeli partner: Traffix Systems Prominent partners: Telefonica, Spain; The Technological University, Berlin, Germany; University of Geneva, Switzerland Budget: 5.5 Million Euros Every cellular phone user knows the limits in his relationship with the service provider. From the moment you sign a contract, you lose control over the management of your user profile and your actual consumption. If you want, for example, to use a cheaper service from a competitive service provider, you are limited with no real mobility available. Personal information isn't properly guarded and companies often harm users' privacy. The project's main goal is to create a continuous mobile environment open to cellular users and end users as to better control cellular service consumption, along with complete control over one's personal information all the while receiving a combined personal consumption report. This is a project with significant social-financialconsumer effects. This revolution will require a change in regulations as well as the need to allow users to be constantly connected, though a highquality connection, to multi-access and multi-operator networks of the future internet. The project will deal with the development and application of protocols designed to match requirements such as mobility, privacy, safety, initialization and transparency and based on experience quality. 13 14 13 Raising Awareness of Nanotechnology amongst Youth NANOYOU Project Israeli partner: Ort Israel; Artic Israel – International Management Services Prominent partners: Cambridge University, UK Budget: 1.8 million Euros Surveys show that most of Europe's citizens do not understand and are unaware of the Nanotechnology's importance and it's potential. The project's assumption is that any increase in the public's awareness in this field will positively contribute to the decision-making process in the future use of nanotechnology. The focus on 11-25 year olds stems from the need to beginning influencing the future's communities. The project includes temporary and permanent exhibitions, innovative computer games, workshops, experiments and online content whose goal is to promote dialog, increasing participants' awareness of the ethical, legal and social aspects of nanotechnology. Storing Carbon Dioxide MUSTANG Project Israeli partners: The Technion; Environmental & Water Resources Engineering; The Geophysical Institute of Israel; Lapidoth Israel Oil Prospectors Prominent partners: Cambridge University, UK; the National Institute for Scientific Research in France; Uppsala University, Sweden Budget: 12 million Euros The global struggle to prevent global warming includes the search for efficient ways to trap carbon dioxide and its storage. This strategy requires research to characterize geological formations and the sites destined for the safe storage of carbon dioxide. The project's objectives are to develop methodologies and tools to assess and characterize suitable deep saline aquifers for the storage of carbon dioxide, while providing measures of risk necessary to prevent environmental damage and ensure public safety. This is the development of original methods to store carbon dioxide with improved abilities to determine the relevant physical characteristics of the site and the short reaction time in inspection and supervision of the process both during the injection as well as the storage phases. A Plastic Optic Fiber - Low Cost with High Transmission Capabilities POF-PLUS Project Israeli Partner: Rosetta IP Prominent partners: France Telecom; Telecom Italy; Eindhoven University, Holland; Fruanhoffer Institute, Germany Budget: 4 million Euros Fiber Optics are central in communication networks in the transfer of large amounts of data. Regarding alternative solutions, fiber optics have a number of advantages such as: simplicity in connection, small diameter, low weight and lack of electromagnetic emissions. The project's aim is to develop a standard, plastic fiber optic with a high broadcast ability and a low-usage cost. The fiber developed will allow for transmission services for wireless and non-wireless for NGN users as well as the deployment of an optical network from the user's home to large information centers and main network storage facilities (FTTH). From Optics to Surgery MiniSurg Project Israeli partner: VisionSense Prominent partner: The Inter-University Centre for Micro-Electronics, Belgium Budget: 3.4 million Euros Advanced medicine makes more and more use of minimally invasive 14 surgery (laproscopic) through optical equipment, such as microscopic cameras. Using this equipment can make the patient's healing process easier and shorten hospitalization periods. VisionSense developed a patented breakthrough technology – a vision sensor activated and controlled by surgery software for minimally invasive surgery. The technology provides the surgeon with realtime lookout, at a high-resolution, with stereoscopic vision this kind of vision provides depth perception, improving surgical abilities, while minimizing the dangers for the patient. The sensor allows a move from two-dimensional optics to three dimensional "smart" visions. The project's goal is to create a jump forward on the current patent – through the developing of an advanced, reduced stereoscopic sensor which will allow for HD broadcasts at a low cost and with highbroadcasting capabilities. Neurosurgical Surgeries Using Miniature Robots ROBOCAST Project Israeli partners: Mazor Surgical Technologies; The Hebrew University of Jerusalem; The Technion Prominent partners: Acrobat Company, UK; The Milan Polytechnic, Italy; Imperial College, London, UK; Karlsruhe University, Germany Budget: 4.9 million Euros No, this isn't science fiction. The project is meant to develop scientific and technological methods to create miniature robots to assist in Neurosurgical, mainly susceptible surgeries, such as brain surgery which requires one to open the skull and demand accuracy. A modular system, allowing a reduction of the footprint, will be developed with two robots and one active bio-mimetic probe, able to cooperate among themselves in a biomimetic sensory-motor integrated framework. A gross positioning 3-Axes robot will support a miniature parallel robot holding the probe to be introduced through the “Keyhole” opening into the skull of the patient The aforementioned technology will be the basis for a variety of possible systems and tools with the aim of guiding the surgeon to the exact location in the brain and allow for the precise application of the surgical procedure. The Next Generation of Conference Calls 3DPresence Project Israeli partner: Radvision Israel Prominent Partners: Telefonica Spain; Phillips Holland; Fraunhoffer Institute, Germany Budget: 5.5 million Euros The project's role is to develop the next generation of online conference calls, based on IP's in a three dimensional environment. This will create the feeling of human presence and a natural impression which will intensify the team members' execution ability. The existing conference call systems have failed to overcome technology's "presence" challenge, which presents a sustainable alternative to business trips (which include costs, lack of comfort, and a carbon footprint caused by plane fuel). The existing solutions, have partially dealt with the existing deficiencies, they are expensive to apply and do not use 3 dimensional images that may allow for far away users to create eye contact and interactions other than in a very limited fashion. The project assumes that joint communication with employees, partners, suppliers and clients spread across the globe, requires a simple, comfortable and user friendly solution. The project will develop a technological solution allowing one to hold 3 dimensional high-quality video conferences with a large number of participants. 15 13 Bar Mitzvah Bar Mitzvah Bar Mitzvah Early Detection of Autism ASD Screening Project Reintegration grant for an Israeli researcher returning to Israel: Dr. Ayelet Ben Sasson, University of Haifa Grant: 100,000 Euros Researchers around the world are attempting to decipher disorders from the Autism Spectrum Diseases through the development of tools for the early identification of this disorder. This kind of identification is necessary to allow for early intervention. Studies have shown that there are many cases of Autism, which can be identified during childhood, but the existing tools have so far only achieved partial success and therefore cannot be applied. The project's goal, with the participation of researchers and leading research institutions around the world, is to examine the forecast period for early diagnosis in children and the applicability of these diagnosis tools as part of the healthcare framework. Post-Stroke Rehabilitation of the Nervous System's Function PLATICISE Project Israeli partner: D-Pharm Prominent partners: Novartis; Glaxo Smith Kline; Zurich University Switzerland; Cambridge University, UK Budget: 7.7 million Euros Nerve degenerative diseases lead to damage of the nervous system's circuits, due to the loss of connectors, axons and neurons. The loss can be gradual, such as in Alzheimer's, or quick, like a stroke. After the damage has been done, the nervous system can partially compensate for the loss of connectors by the creation of new paths, a process called plasticity. Adults can acquire renewed function after a stroke and compensate for the loss of cells from Alzheimer's, for example, but only until it reaches a critical level. Children, on the other hand, have the ability to compensate for the damage incurred in the central nervous system at a much higher level in most cases. The overall concept of the project, is the belief that treatments that enhance plasticity will become one of key medications that will improve neurological function in the damaged human nervous system. The purpose of the project is to bring this moment closer. Genetic Enhancement of Plants to Increase Yields RECBREED Project Israeli partners: Weizmann Institute of Science; O.S.M.-DAN Prominent partners: Keygene, Karlsruhe University, Germany; National Institute for Scientific Research, France Budget: 4 million Euros The significant shortage of food in the world has lead, in recent years, to a real crisis. One of the solutions to the problem, directly connected to population growth and as a derivative of the increased demand for food, is the genetic enhancement of plants used for agricultural crops. Successful and efficient plant breeding depends on rapid recombination of advantageous traits to form new crop varieties. In recent years new breeding techniques have been introduced which rely on transgenic alteration of somatic cells and regeneration into plants with novel properties. The objective of the project is to provide plant breeders with new tools, allowing better control over homologous recombination in plant cells. The expected outcomes of the project are efficient gene targeting technologies for precise engineering of plant genomes. An Innovative Treatment for a Rare Genetic Disease EUROTRAPS Project Israeli partner: Pronto Diagnostics Prominent partner: The National Institute for Health and Medical Research, France Budget: 3.8 million Euros TRAPS (TNF Receptor Associated Syndrome) is a rare disease, caused by a Bar Mitzvah mutation in the TNFR1 that leads to renal amyloidosis, which in up to 20% of cases may be fatal. It is characterized by recurrent bouts of fever and pain and it is usually associated with patients of European descent. The existing treatment has not been proven as effective in the control of these bouts and the prevention of renal amyloidosis. The project has led to the creation of an interdisciplinary consortium, which combines ideas, resources and datum from research institutes and business corporations from six countries, with the aim of gaining insights into the natural course and pathophysiology of TRAPS, particularly in children. The goal is to identify the disease mutations and develop new treatment methodologies to ease the symptoms and therefore improve the welfare of the patients and their families. Genetics and the Family From Child to Parent Project – ERC programme Winning researcher: Dr. Ariel Knafo, The Hebrew University of Jerusalem Budget: 1.4 million Euros What affects the social behavior of children – nature or nurture? This project is the first one to directly address these issues with DNA information on family members and quality observational data on parent and child behaviors, following children through early development. Pilot results show children’s genes predict parenting, and an important task for the study will be to identify mediators of this effect, such as children s temperament. The project will lay the ground for further research into the complexity of geneenvironment correlations as children and parents co-develop. Composite Materials Profiles for the Aerospace Industry IMac-Pro Project Israeli partner: Israel Aerospace Industries Prominent partners: Eurocopter Germany; Dassault France; EADS Germany; Alenia Italy Budget: 8.9 million Euros The project goal is the development of an industrial process which combines the major airplane manufacturers and material suppliers to create a variety of robust aeronautic profiles of composite materials. The project will focus on the cost-effective manufacture of geometrically complex profiles with changing dimensions and single or multiple curvatures. The technology developed as part of the project has a significant potential for the efficient manufacture of aeronautic profiles such as floor beams, structural stiffeners, frames, spars and truss structures that are lightweight and designed optimally to withstand operating loads in service. Advanced Manufacturing Technology for the SemiConductors Industry MAGIC Project Israeli partner: KLA-Tencorn Prominent partners: The Institute of Atomic Energy, France; Fraunhoffer Institute, Germany; STM Micro Electronics, France; the Microelectronic Institute, Stuttgart, Germany; FUJIFILM Electronic Materials (Europe), Belgium Budget: 20 million Euros The project is intended to support the development of ML2 technology for the CMOS manufacturing environment of the semiconductor industry. This technology develops lithography aimed to overcome the limitations in the manufacturing of CMOS technologies which make use of optic lithograph techniques based on lubrication: limiting the complexity level and manufacturing costs. The project is supported by the largest CMOS manufactures in the world, including: STMicroelectronics, TSMC, Toshiba and Texas Instruments. The project runs to develop a basic ML2 platform suitable for 32 nanometers. The platform will include a programme which deal with the basis of information and which carries out production control. At the end of the project an ability demonstration for the integration of CMOS processes in a manufacturing environment on the ML2 platform will be presented. 15 16 13 When Israeli Capabilities Meet European Capabilities Joel Tsafrir Dozens of Israeli companies and academic research organizations collaborate on a variety of projects with their counterparts in Europe, as part of the European Framework Programme. We gathered a number of representatives from these organizations to get their impressions regarding the benefits they gained from participating in the programme in terms of knowledge, experience, capital and business ties Nowadays, when Israel's image is at a low point, just look at the Goldstone Report, it is important to point out that there are a number of actors in Europe, both in industry and academia, which percieves Israel differently. These are companies and corporations, research institutes and universities, constantly in touch with their Israeli counterparts in the framework of research and development projects, which are part of the European Framework Programme that advances cross-border collaborations in the field of R&D. Many Israelis testify that the direct contact with representatives of companies and academia, which has more than once led to personal friendships, has changed Israel's image in European eyes. Those used to seeing Israel on television screens, as a violent country which abuses human rights, have suddenly discovered a liberal, advanced, lively and vibrant society, rich in knowledge and technology, of which Europe can derive significant benefits. What began as a first visit for many has become a series of visits and tours, intensifying the Israeli-European relationship. "I have said more than once, jokingly, that we should get funding from the Ministry of Foreign Affairs for our contribution to Israel's image and Israeli propaganda," says Marcel Shaton, the General Manager of ISERD, The Israel-Europe R&D Directorate responsible for the coordination of Israel's activities vis-à-vis the European Commission regarding the European Framework Programme. Shaton, himself a renowned and respected diplomat, is aware of the benefits Israel derives from its integration in the European Framework Programme in all fields, financial and political as one. There is no doubt that he also draws encouragement from the Programme's success, as one of the pioneers that advanced the integration of Israel into the European R&D programme, while a number of local voices that were skeptical at first. Today, 13 years after Israel joined the Framework Programme, we can pause and summarize the benefits Israel has thus far derived from the Programme in different fields. For this, and to mark the "Bar Mitzvah" year since Israel joined the European R&D programme, we assembled a panel of representatives from a number of companies that have participated, or are currently participating, in different projects within the European Framework Programme for Research and Development. Leveraging Knowledge One of the strong sentiments which arose during the panel was that participation in the projects, beyond the financial aspect, allows for mutual inspiration between Israelis and Europeans, inspiration that provides concrete added value and knowledge. "As someone who participated in a number of projects, I am a strong believer in the European Framework Programme for Research and Development", says Avi Gal, R&D projects & Alliances Director at Gilat Satelite Networks. Participation in the projects allows for mutual inter-cultural inspiration, between representatives from different countries, each of which comes from a different organizational culture. You could see how everyone gathers around one table, Germans, Greeks, Belgians and Israelis, discussing and exchanging ideas, through an inclusive and comprehensive view of the big picture. If throughout the meetings a successful collaboration is formed, actual inspiration is created and everyone wins. You can even collaborate with competitors and continue to compete with them afterwards, or simultaneously, on the business field. This combination is particularly applicable when discussing the development of future technology. That is the uniqueness of the Framework Programme and I very much believe in it". Eyal Neria, CEO of CapsuTech, a young biotech company which works within the incubator of Nazareth, discusses the many options available for small companies, particularly in accessing the huge medical companies in Europe. "The project we are occupied with is defined as a collaboration between academia and industry. Our involvement enables us to leverage the knowledge we acumulated. The consortium includes leading research organizations and academia and of course top medical researchers. For example, Dundee University in Scotland – a leader in cancer research, a field in which we specialize – the University of Haifa and the Israeli company InSightec. These also deal with important strategic issues in the field of medicine and are at the forefront of medical research, such as medical simulation, ultrasound or designing the future operating room, and I have no doubt that we couldn't have reached them without having participated in the European R&D programme". And indeed, the ability of small enterprizes to get access to large projects involving huge corporations from Europe is seen as an important advantage of the European Framework Programme. Gerardo Nahum, Managing Director of Rosetta IP from Netanya which works in the field of microchips, knows all about the integration of a young company into a large European project in the field of optical communications. Partners in the project, whose goal is to lay down a plastic optic cable for household communication, works to decrease the costs of available communications. Those huge corporations in the field of communication, such as "France Telecom", and "Telecom Italy," along 13 Bar Mitzvah Bar Mitzvah Photo: Ziv Sade Bar Mitzvah 17 Bar Mitzvah Right to Left: Avi Gal, Eyal Neria, Chaim Rafalowski, Gideon Hazzani, Prof. Oded Maimon, Vered Ariel-Nahari, Gerardo Nahum, Marcel Shaton, Joel Tsafrir, David Tolub with additional significant players such as research institutions from Germany, large laboratories and additional organizations, welcomed the participation of Rosetta IP. Nahum claims, that the participation in the project also enabled the company to raise foreign investment. This combination between access to laboratories and equipment at a scope that no small company could achieve on its own, along with strengthing the image and rasing capital, seems to Nahum as proof to the importance of integration into the European R&D programme for small Israeli companies. Both Nahum and Neria agree that participation in the European Programme is a significant and powerfull leverage for small and medium sized enterprizes. In addition, they believe that the funding for small companies should be increased as opposed to large companies. In their opinion, for small and medium sized enterprizes it is important to integrate into projects with immediate consequences and not just long term. Chain Reaction In addition to business organizations, public organizations also take part in the Framework Programme. One of the interesting examples of cooperation is the integration of the Israeli Magen David Adom (Israel's first aid services) into European projects, particularly regarding the preparation for large-scale disasters. Chaim Rafalowski, EU Projects & DM Coordinator in MDA, speaks of their participation in a European project whose goal was to map out the medical needs in case of large-scale disasters. "The project examined the existing technologies and pointed out the gaps to be bridged, all this with the help of end users and those in the field from all countries. In addition, the project had partners from academic organizations and research institutes and led to a significant breakthrough related to preparations for large-scale disasters, through cross-sector collaborations between the business security sector and the civilian rescue sector. This was a unique and particularly interesting experience for us. Up until two years ago we didn't know anything about the European R&D programme". Another important aspect raised by Rafalowski is the dialogue which developed between colleagues in Europe. "Very strong networking was created. Suddenly we realized we weren't the only ones in the fight against terror. Europe too has its problems as well as limited resources. Therefore, the search for new technologies, which provide answers for joint problems, through an extensive dialogue between them and the industry is at the which exhibit this advantage. Europeans, so it seems, are occupied with the field of Homeland Security. Gideon Hazzani, Director of new business technologies in VERINT, spoke of two central European projects that the company participated in, as the leading provider of software-based analytical solutions for the security and business intelligence markets. VERINT's solutions transfer voice, video and text to applicable information – necessary and informative insight to achieve strategic goals. The first project is aimed at handling emergencies and national disasters such as large-scale terror attacks, accidents in large plants posing threats of environmental disasters, enormous fires and so on. The idea is to translate VERINT's abilities from the field of military intelligence to the civilian world, "Our ability to understand where the market is going is an important advantage which stems entirely from our participation in the European Framework Programme. The ability to know what is on Europe's technological agenda is very valuable information" core of the project," highlights Rafalowski. One of the main advantages pointed out by Chaim Rafalowski is that participation in one project led to participation in additional projects. These are important projects wherein the partners are organizations which are similar or paralel to MDA in Europe, such as Madrid's Ambulance Company, Ambulance Services in Holland and the Austrian Red Cross. In addition, collaboration with Al-Quds University in East Jerusalem was created as part of the European Effort to encourge an Israeli-Palestinian dialogue. All panelists agreed and sopke of similar instances with the aim of enabling decision makers to get a real-time picture of the event's development so as to make informed decisions which will reduce the uncertainty and minimize the number of casulties. Large-scale disasters lead to feelings of extreme fear and chaos and therefore the technology's goal, amongst others, is to minimize the feeling of panic and to reduce the damage caused to decision makers due to this. The project combined many technologies from Israel and Europe and its budget stood at 9.1 million Euros. 18 13 Another project was related to airports security, which have become sensitive zones and a target to terror attacks, in recent years, favored by extreme terrorist organizations. Here too, Verint was asked to combine its abilities in the field of intelligence and video technologies to help secure airports. No less than 20 different organizations in Europe partook in this project including end users and clients, amongst them Heathrow Airport in London. The project's highlight was the attempt to mold the concept of European security in general and particularly in airports as we head closer to the Olympic Games in London in 2012. Access to Knowledge An additional aspect which arose during the panel was the access to new knowledge in Europe. David Tolub¸ President & CEO of "OVERSI", a software company that develops solutions to reduce overload traffic on communication networks, claims that thanks to the integration of Israeli companies into different R&D projects they are granted access to important new knowledge that is created through the cooporation with large corporations from Germany, France, Great Britain and more. This is the remarkable ability of Israelis to plug into important sources of knowledge and enrichment. Later on this knowledge can be imported to Israel. Tolub tells, for example, of the involvement of his company in a European strategic project which is trying to shape the future of the internet. The presumption is that over 90% of internet traffic will be video files and the project deals with the evaluation of the next generation of video. OVERSI's technology which deals with the transfer of information between users without a central server, by transferring large amounts of information at high-definition quality, integrated well into these projects. "Our ability to understand where the market is going is an important advantage which stems entirely from our participation in this European project," highlights OVERSI's General Manager. Tolub agrees that the access to large-scale resources is a clear advantage for Israeli companies, but also raises another interesting point. Participation in research projects allows the managers to allocate manpower for long-term planning, as well as appropriate financial backing. "Many managers in Israel deliberate extensively between what is pressing and what is important, between caring for customers immediately and long-term future planning. The integration into European projects forces the managers to allocate manpower to the project which is entirely focused on future developments." Avi Gal of Gilat also agrees that the ability to know what is on Europe's technological agenda is very valuable information which assists Israeli companies, all of which is in addition to the benefits found in long-term strategic thinking. "We, for example, didn't know anything about a European project that was supposed to ensure communication accessibility to remote rural 18 Wanted – Intellectual Openness Differences in organizational culture are a recurring issue in any discussion concerning encounters between Israelis and Europeans. According to Chaim Rafalowski from MDA this is an unavoidable situation that often leads to frustration: "The culture differences between us and Europeans are significant. In Israel the approach is command-like, stemming from the IDF, where the commander is the one that decides. The Europeans, on the other hand, emphasize consensus and reaching agreements, even at the cost of slowing things down. The latter can be very frustrating for Israelis that feel that the discussion is over and it is time to end it. But those who want to work outside of Israel must adapt themselves and experience different thinking processes. Although it's not easy, it's part of the projects' charm. It requires us to have intellectual openness which assists us in additional fields. For example the need to cooperate with additional sectors such as the industry." Eyal Neria on the other hand, sees this as a successful match, despite the differences between Israelis and Europeans. "The Israelis bring with them creative and innovative ideas, as well as improvisation skills. They are to the areas. This suits our vision and the fact that we were exposed to such projects, even if not always at a senior status, ensured a connection to the communication strategy in Europe. This is very valuable knowledge." Gal shares Tolub's opinion about the importance of financing for the development of long term projects. "It is important not only to small companies, but also for large companies, as sometimes future development competes against current developments and the ability to raise funds for the future definitely influences positive decision making in that direction." Change of Orientation A considerable number of managers that participated in the panel admitted that the meeting with the Europeans led to a change in their attitude towards Europe. Prof. Oded Maimon, from the Industrial Engineering Department of Tel Aviv University, who participated in two projects in the field of nano-technological and biological engineering, exclaimed that up until a few years ago the academic orientation was completely American. "Thanks to the participation in European projects we changed direction and now we often work with Europe. We learned to appreciate the EU's abilities and, one has to admit, the cultural and geographical proximity. It is important to remember that Europe offers Israelis a combination of large R&D centers, huge corporations, diverse research organizations and universities all of which are partners in these various projects. The research partnerships with Europe lead us to depend less on donations and more on the integration into research projects. This is a huge advantage. Beyond this, the funding point and direct. The Europeans may be more organized and less interested in short-cuts, but this match between Israelis and Europeans actually pushes to innovation and cooperation, while thinking out of the box." Avi Gal claims that the Europeans have learned to respect the Israeli companies and their competitive status in the world. "For example, we are considered global leaders in the field of Satellite Networks, second only to the United States and leaders in Europe. The Europeans appreciate this and want to hear what we have to say." In his opinion, when the collaboration is with a different organizational culture, the rules also apply on industry-academia ties, each of which speaks a different language: "Assembled around one table are representatives from different sectors. The academia looks further ahead and at times that makes it difficult on the industry. But then it turns out that a dialogue has evolved, as many researchers are interested in the problems that arise in the field. The important thing is not to give up. Everyone comes with their own point of view and the dialogue leads to mutual inspiration, by combining the different angles." we received is much more than we could have raised on our own. For example, the budget we received for PhD's participating in the projects is three times that of other researchers in academia. A serious and new momentum has been created here which we lacked beforehand." To conclude, the panel's participants emphasized, unanimously, that the main advantages and benefits, for business and public organization alike, by participating in the European projects of the Framework are: an incentive for innovation, business connections and exposure to capital and resources at a particularly largescale, alongside access to research centers, collaboration, and exposure to new markets and customers. In short, this is a significant platform for business development, both in the short and long term. Investing in Proposal Writing One of the important subjects in the process of accepting a company into a European project is the quality of the proposal submitted. Israelis tend not to put enough effort in writing the proposal, Chaim Rafalowski from MDA cautions, in addition they don't understand the weight Europeans ascribe to a well written proposal. In his opinion, "As Israelis we have many advantages, but we tend to present proposals that are lacking or forget entire chapters. This isn't a complicated process, but more than once a good idea has been rejected due to a poor proposal. It is important to insist on preparing the proposal as required and there are very clear rules that cannot be deviated from. Although there is no replacement for a successful idea, it is unfortunate to lose out due to technicalities." 13 Bar Mitzvah Bar Mitzvah Bar Mitzvah Bar Mitzvah Ten Recommendations How to Participate in European R&D Projects 1 Participating in the consultative presentation The presentation explains the program and its goals. This explanation is imperative to adjust one's expectations. Start thinking NETWORKING 2 3 One-on-one meeting with ISERD's experts Identify the relevant issues in the business plan. Get used to thinking NETWORKING Take immediate action Understand the schedule and plan steps in advance. Build NETWORKING steps 4 5 Attain system support and obtain resources. Develop NETWORKING capabilities Collect information Learn from similar projects and discussions with participants. 6 Recognize NETWORKING targets 7 Raise support Act like a European For the Framework Programme you are considered an integral part of Europe. Travel to NETWORKING meetings Apply to ISERD's support fund Financial aid to integrate into the Programme. Invest in NETWORKING 9 8 Awareness of the different kinds of participation available Set-up collaborations Understand the abilities and needs of your future partners. Respect your NETWORKING colleagues Coordinator? Entrepreneur? Partner? Focus your NETWORKING efforts 10 Join the club The investment bears fruit in the long term as well. Reap the rewards of NETWORKING 19 20 13 ISERD's Team Information and Communication Technologies; Research Infrastructures Mr. Aviv Zeevi-Balasiano Director Tel: 00-972-3-5118121 [email protected] Ms. Hadas Daar Projects Officer Tel: 00-972-3-5118123 [email protected] Mr. Felix Cincarevsky Projects Officer Tel: 00-972-3-5118167 [email protected] Nanotechnologies, Materials, Production; Transport (incl. Aeronautics); Space; Security Dr. Nili Mandelblit Director Tel: 00-972-3-5118120 [email protected] Health; Food, Agriculture and Biotechnology; Environment; Energy Dr. Rami Kalfon Director Tel: 00-972-3-5118119 [email protected] Ms. Adi Yaniv Projects Officer Tel: 00-972-3-5118171 [email protected] Mrs. Lior Ben Artzi – Gershon Projects Officer Tel: 00-972-3-5118182 [email protected] People (Marie Curie); Social Sciences & Humanities; Science in Society Mrs. Orly Mulla Projects Officer Tel: 00-972-3-5118181 [email protected] Mrs. Mika Mor Projects Officer Tel: 00-972-3-5118191 [email protected] Ms. Smadar Hirsh Director Tel: 00-972-3-5118126 [email protected] Mr. Alon Rubinstein Projects Officer Tel: 00-972-3-5118125 [email protected] Ms. Noa Gur Advisor Tel: 00-972-3-5118190 [email protected] Mrs. Vered Ariel-Nahari Advisor, Head of PR Tel: 00-972-3-5118168 [email protected] Mrs. Tony Levy Information & Web Specialist Tel: 00-972-3-5118180 [email protected] Mr. Eyal Bashevkin System Administrator Tel: 00-972-3-5118176 [email protected] Management Mr. Marcel Shaton General Manager & ERC Tel: 00-972-3-5118122 [email protected] ISERD is holding weekly seminars to introduce the seventh framework programme Call for more details and registration Tel: 03-5118122 ISERD, Beit Hataasiya, 29 hamered St., Tel-Aviv www.iserd.org.il Ms. Nitsa Porat Secretariat Tel: 00-972-3-5118122 [email protected]